INmune Bio Inc. (INMB) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Inmune Bio Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:22.300 -- 00:00:24.540 Thank you. 00:01:31.438 -- 00:01:37.100 Welcome to InMuneBio's second quarter 2026 earnings call. 00:01:37.100 -- 00:01:41.242 At this time, all participants are in a listen-only mode. 00:01:41.242 -- 00:01:46.304 Following the presentation, there will be a question and answer session, at 00:01:46.304 -- 00:01:50.826 which time you may press star one to ask a question. 00:01:50.826 -- 00:01:53.587 As a reminder, this conference call is being recorded. 00:01:53.587 -- 00:01:59.350 A transcript will be available approximately 24 hours after the call. 00:01:59.350 -- 00:02:04.902 Before we begin, Please note that except for statements of historical fact, 00:02:04.902 -- 00:02:09.984 statements made by management and responses to questions may constitute forward-looking 00:02:09.984 -- 00:02:15.045 statements within the meaning of the safe harbor provisions of the Private Securities 00:02:15.045 -- 00:02:18.546 Litigation Reform Act of 1995. 00:02:18.666 -- 00:02:23.728 These statements involve risks and uncertainties that could cause actual results to differ 00:02:23.728 -- 00:02:26.989 materially from those expressed or implied. 00:02:26.989 -- 00:02:31.216 Please review the forward-looking statements disclaimer in today's earnings release and 00:02:31.216 -- 00:02:36.457 the risk factors described in the company's filings with the SEC, including its most 00:02:36.457 -- 00:02:41.419 recent quarterly report. Forward-looking statements speak only as of the date they are 00:02:41.419 -- 00:02:46.460 made and exempt as required by law. Immune Bio undertakes no obligation 00:02:46.460 -- 00:02:51.681 to update them. It is now my pleasure to turn the call over to Immune Bio's Chief Executive 00:02:51.681 -- 00:02:54.761 Officer, David Mos...